|
|
Sitemap - Home
- News
- Lens produces hours of scientific work in seconds
- FDA seeks $4.5 billion to promote public health
- Medivation & Pfizer to terminate their collaboration to market development of Dimebon
- Determining the Preclinical Toxicokinetic Comparability for a Biosimilar Drug
- Antares Pharma Licenses A Drug Delivery Technology To Pfizer
- Research partnership between Humana and Pfizer
- Size of Indian Pharma Market
- New Vaccine for Malaria
- Teva might launch generic Lipitor: Analysts
- Indian pharmaceutical industry has tremendous potential to grow from the current levels
- Pharmaceutical Advantage For India
- Reddy formula
- GlaxoSmithKline Pharma: In sound health
- Brit scientists find way to store vaccines in room temp
- Russia invites Indian pharmas for joint ventures
- Pharma industry deserves priority status
- Biogen Idec lines up big India push
- Indian pharma in midst of corporate transformation
- GSK sees growth shot in vaccines
- From Oceans to Crops, and From Crops to IPO
- Expectation of Indian Pharmaceuticals and Health Science Industry
- Pharma cos hope R and D sops will boost investment
- Entry of Global Pharma in generics to put strain on Indian cos
- India still not lucrative for innovator drugs
- Elder Pharma opens drugmaking unit in Uttrakhand
- Excise removal can trigger Rs 5k crore pharma investment
- Opportunities galore in nanotechnology: IISER Director
- Soon, Cancer drugs at half-price from govt outlets
- Cipla retains top slot in domestic pharma market
- No place like home, finds Indian pharma
- Govt plans Rs 2,000 crore fund for pharma research
- Pfizer India, Arpana USAID Expand Public Private Partnership to Strengthen Healthcare Systems and
- Opportunities for NRIs to invest in pharma sector in India
- GSK inching closer to deal with Dr Reddys?
- Life science firms up hirings
- Bafna Pharma to focus mainly on life-style products
- Cadila Healthcare sets April date for the launch of H1N1 vaccine
- Piramal Healthcare to raise Rs 10 bn in 6-8 months
- Pharmaceutical sector has capacity to double exports in five years
- Pfizer, Like Much of Big Pharma, Pushes Further Into Generics
- Dishman sees Crams biz growing 20 percent
- Govt to examine Suns breast cancer drug
- Pharma cos see opportunity in India
- Pharma deals in India: 2009 precursor to what 2010 holds
- Dr Reddys to strengthen domestic business
- Dr Reddys all set to become 3-billion US dollars Company
- Glenmark to outlicense one molecule in FY10
- 2009 Cheers and Jeers for Pharma
- Vaccines enjoy renaissance in pharma industry
- Indian drugmakers leap ahead with Big Pharma
- 2009: The Year Pharma Learned to Love Itself
- As molecule deals fall, pharma firms see cure in late licensing
- Top pharma cos step up R and D spending to boost presence in regulated, emerging markets
- Govt wants PSUs to make H1N1 drug
- FMCG, pharma fledglings in for better days
- Outsourcing steroid for Indian pharma firms
- Gujarat pharmaceutical companies return home
- Pharma groups plan anti-diarrhoea vaccine
- Modi asks pharma cos to focus on real research
- Vitamins or overpriced nutrients? Pharma firms face probe
- CRAMS factor
- Cipla in talks to supply drugs to Germanys BI
- Blow the whistle on fake drugs, and get rewarded
- Aventis launches rural market division, eyes 2 per cent share in 5 yrs
- Pharma industry to need 2 lakh more grads by 2015
- Belgium-Gujarat diamond ties may extend to pharma
- Cracks in doctor freebies code
- Local firms must step up biologics play
- Piramal to strengthen diagnostic services
- Pharma firms to conduct H1N1 vaccine human trials in India
- India, Russia to raise bilateral trade to $20 bn
- BUZZ IN PHARMA BIZ
- Indian pharma world discovers Bharat
- DISCOUNT PILLS
- Dragon emission cuts bite pharma industry
- Govt to step up pharma research in country
- Generating Synergies between India and Central Germany
- Govt plans Rs 2,000-cr corpus for pharma sector
- India has 'world-class health care', say Canadians
- Aurobindo Pharma aims to treble revenue by 2014
- A.P. number one in pharma exports
- Model N to spruce up India Operations
- In healthcare, we can at best play catch-up with China
- Novo Nordisk eyes India as insulin hub for sub-continent
- Suven Life Sciences plans to raise funds for clinical trials
- Medicis deal, generic biz to boost financials
- Cipla's swine flu drug Antiflu hits market
- E7 the new El Dorado for pharma
- Watch out for US recovery, new products
- BIG PHARMA AND BIOTECH
- US health bill to benefit local generic firms
- Biocon hums with plans, pitches for global top 3 slot
- Zydus first Indian co to file H1N1 clinical trials
- NEW MERCK BEGINS OPERATIONS WORLDWIDE
- Sikkim turns into a pharma hub
- Not the right medicine
- Pharma slows down, grows at 9.6 percent
- India is growth tonic for mid-tier global pharma
- Ranbaxy sells Vietnam biz, to exit another in growth bid
- Cadila Pharma eyes Rs 80 crore from Risorine
- Pharma club seeks protection from foreign predators
- Big Pharma cures for ailing heritage
- Global Coalition to observe first ever World Pneumonia Day on November 2
- Swine flu fever
- State continues to attract pharma industry
- Dabur India to merge Fem Care Pharma with itself
- Glaxo enters DMD drugs with Prosena
- NPPA wants generics branding out
- Vitamins boost pharma growth
- Dr Reddys net rises 106 percent on cost cuts, higher sales
- Pfizer scans India for shopping options
- Apollo Pharmacy licensed to retail Swine flu medicine
- India govt seeks Argentina to ease trade policy to increase pharma trade
- Govt may cap retail price of swine flu drug
- Glenmark Pharma plans to list its generics subsidiary
- Piramal Life lines up Rs 200 cr for new drug research
- Pharma cos likely to emerge stronger in Q2
- Vivimed Labs in Rs 130cr expansion
- Indian pharma market set to grow 12 to 15 percent
- American trio share Nobel Prize for hot area in pharma research
- Reflections On The Indo Africa Pharma Business Meet
- Growth in US, local market to pep up DRL
- Wipro GE Healthcare to integrate GE Healthcare units in India and South Asia to accelerate growth
- Indian formulation mkt to cross US dollars 13.7 billion by 2013
- Pharma M and As sounding death knell for low-cost drugs?
- Pharma industry steps up recruitment 5 times
- Indias genetic divide may hit pharma cos R and D plans
- Wockhardt is top Indian pharma patentee bags government award
- Pharma exports up 29 pc to US dollar 9.35 bn
- Sanofi-Aventis scans India for acquisitions
- Mega deals boost pharma in crisis
- Lotus aims to roll out 4 more centres next year
- Pfizer plans major push into generics
- 2009 India Excellence in Healthcare Awards
- Pharma cos will require DCGI nod for exports
- Annual India Excellence in Healthcare Awards to Celebrate Best in Industry
- Roles reverse in pharma M and As
- India pharmaceutical market currently ranks 13th among the major global markets
- Race for a H1N1 Swine Flu Vaccine
- North Indian Pharma: Focusing on R and D and Tie-ups to Meet Challenging conditions
- Indian generics profit from Glaxo patent expiry
- Big pharma companies join outsourcing queue
- Foreign pharma firms likely to beat Indian ones in developing vaccine
- Impact Of Current Global Conditions On Pharma and Biotech
- Cadila Pharma plans swine flu vaccine by November
- Low costs a draw for foreign drug makers
- Pharma sector in good health in June quarter
- Pharma sector in for an R and D boost from govt
- Pharmaceutical Outsourcing Congress India 2009
- Indias drug discovery efforts suffer failing health
- Opportunities for Indian drug makers in SA
- Generic drugs to carry quality mark
- Risk adjusted Vs absolute returns on pharma companies
- Indian Pharma mkt valued at Rs 55,000 cr in FY09
- Protectionism hurting Indias trade with EU: FICCI
- Sanofi Pasteurs Shantha buy a shot in the arm for Indian Pharma.
- India set to sign pharma export deal with Nigeria
- Pharma companies looking to Womens Health for growth
- Frost & Sullivans Food & Beverage Focus 2009
- A Patently Good Idea
- Exploit more, explore less is Dr Reddys strategy in tough conditions
- Pharma cos may show a mixed bag in Q1
- Indian pharma firms swallow bitter pill in US, Europe
- Animal Health offers growth for Big Pharma
- Israel ranks high in counterfeit pharmaceutical trade
- Pharma Accused of Keeping Good Generics Down
- Dabur eyes acquisitions up to Rs 500 cr in healthcare
- Indian pharma firm sets up subsidiary in Romania
- Strong dollar beats down pharma revenues
- Gujarats 36 pharma brands among Indias top 300 cures
- Pandemic flu shows need for pharma incentives WHO
- Pharma body bans discounts, elderly cry foul
- Sun Pharma: A dose of good news
- Sciele Pharma & Victory Pharma agree to terminate merger agreement
- Dark clouds loom on Big Pharma horizon
- HEADLINE: India - a force to be reckoned with?
- PerkinElmer expands presence in India with new Center of Excellence in Hyderabad
- EU Raps Big Pharma, Indian copycat kings boosted
- Galapagos to get 5.2 mn Euros milestone payment from osteoarthritis alliance with GSK
- Pharma major comes to aid of school with a difference
- Pharmaceutical Industry at Crossroads
- Sun Pharmas US arm cuts 350 jobs
- Cadila Pharma-Novavax JV to produce swine flu vaccine
- Pharmas biggest boost comes from removal of fringe benefit tax news
- Big Pharma Looks To Branded Generics in Developing World
- ELDER PHARMACEUTICALS SETS UP ELVISTA A DIVISION DEDICATED TO TAP RURAL MARKETS
- Pharma giants feel afflicted with higher MAT
- FM has a heart, and a liver too
- Global pharma sales growth falls to 4.8% at US dollars 773 bn in 2008: IMS
- Pharma sector draws hope from Survey proposal on price controls
- Pharma, not IT, is Indias next big thing
- Piramal to be first pvt company to process opium
- Pharma industry hails survey recommendation on drug prices
- Sanofi-aventis presents new R & D model project to boost innovation
- Piramal Healthcare invests Rs 100 cr to expand business, sets up facilities in Ahmedabad, Chennai
- Wockhardt to sell Animal Health Division to French firm
- From Thieves to Golden Geese
- Japan's Astellas Pharma plans to enter Indian mkt
- Generic cos board biosimilars wagaon
- UK cos eye tie-ups to tap $1 bn clinical research market
- Big Pharma comes calling to India
- Indian pharma industry to grow at 15 percentage - KRN Moorthy, Wanbury
- EU’s demands may impact generics
- China to Chennai is the new route for spurious medicines
- Drug daddies keen to pop local deal pills
- How Budget can help pharma sector
- Global Pharma majors impressed with Indian Bio-Pharma IP adherence
- Glaxo, Reddys team up in emerging marketsJune 15, 2009
- Dr Reddys Laboratories to hire 1,300 this year
- Consolidation helps foreign pharma majors lead the India rank list
- Instant remedy: Pharma co ready with swine flu vaccine
- Report on pharma innovation to be released at USIBC meet
- Pfizer eyes deals to raise emerging markets presence
- India lodges protest against Chinese drugs with fake 'Made in India' tag
- Indian pharma faces the big-league challenge
- Pfizer eyes partnerships, acquisitions in generics
- India to prepare case on drug confiscations at European ports
- Big Pharma gets gold star on climate change scorecard
- India can become a global pharma innovation hub: experts
- To maintain quality of medicines, IGI to get pharma zone
- Pharma firms continue to face patent violation charges in Europe
- First indigenously developed Indian drug to come up in 2-4 yrs
- Pharma New World Order
- Drug makers eye Cambodia
- The pharmaceutical industry faces unprecedented barriers to evolution
- Evolvence to invest in Indian pharmaceutical companies
- Life sciences industry awaits health supplement in Budget
- World Recession Slowing Down Global Pharmaceuticals
- Pharma industry seeks income tax exemption for R&D
- Drug-resistant bacteria mute antibiotics R&D
- Heard on the Street
- Gujarat-based pharma firms in pink of health
- Indian Pharmaceutical Industry Capable of Dealing with Any Situation
- India now a player in M & A premier league
- Over 44 fixed-dose combination drugs clear DGCI tests
- Cardiome bags US 60 mn dollar from Merck as collaboration, license pact become effective
- Indian pharma players to benefit from generic drugs in US
- Pharma Trials Heading South
- Novartis nabs Ebewe for generics push
- Pfizer nabs generics, emerging-market rights
- Cancer drugs may come under NPPA lens
- Dr Reddys to tap rural, north Indian markets for growth Plans to increase products in therapeutic
- Japan’s Pharma Sees Growth in Generics
- Pharma firms look to profit from waste
- Pharma exports down on health cost cut in rich nations
- Japans Takeda to buy IDM Pharma in cancer drug push
- Lonza to build new cell therapy facility Singapore
- Ireland wants to increase bilateral trade with India
- Pharma cos want new govt to boost spending, push reforms
- The outsourcing boom grows for non-core pharma activities
- Pharma sector hails UPA win, expects continuity of eco reforms
- MNC units abroad to come under drug regulator scanner
- Lupin to raise stake in Australian firm to increase market presence
- Govt moots setting up pharma zones at airports, seaports
- India looks to China for exports
- As pipeline dries, Big Pharma resorts to evergreening
- India`s pharma exports to US tumble 37%: report
- Pharma cos seek rise in prices of regulated drugs
- Global HIV/AIDS initiative to help Indian Pharma
- Glaxo goes deeper into Africa with US dollars 418M deal
- Pharma cos recast European operations to protect margins
- Pharma MNCs can't experiment with India yet
- Indian pharma cos upbeat on biogenerics
- Pharma cos may have to start collaborating
- Pharma cos seek retail opening for swine flu drug
- Logistics cos gear up to tap slump-proof pharma sector
- Indian drug sales suffer
- Roche donates 5.65 mn packs of Tamiflu to WHO
- Kokilaben Hospital makes Trilogy radiation therapy available for first time in India
- Dip in US drug sales may hit Indian cos
- India approaches WTO against EU on drug seizure issue
- US FDA authorizes emergency use of flu medicines, diagnostic test to tackle Swine flu outbreak in hu
- GSK calls for public health emergency of global concern
- Indian Pharma Primed For Growth
- India emerges as best option for contract manufacturing: Global Pharmatech Chief
- Not too enticing
- MNCs oppose affordable patented drugs
- Govt gives diplomatic push to pharma exports to Africa
- Pfizer, MVV ink pact to fight against malaria
- Pharma cos adhere to EHS to attract global business
- Sanofi-aventis builds new manufacturing site in Binjiang New Development Zone
- Pharma welcomes UK taxation pledge
- IMS Health Cuts Pharma Growth Forecast
- China ripe for Big Pharma Growth
- Centre to talk MNC pharma cos into keeping a check on prices
- Pharma companies headed for slower earnings growth: analysts
- Drug firms may exceed growth targets
- ICCI for encouraging local pharma industry
- G20 economic stimulus packages offer little direct aid to branded pharmaceutical players
- India's Marck Biosciences Enters Malaysian Pharma Sector
- Abbott profits soar but pharma hit by generic competition
- Pharma giant Roche posts 7 pct sales growth
- Natco Pharma inks pact with Dr Reddy's Lab
- Pharma cos have it tough this quarter
- Novartis in hiring mood- in China.
- AstraZeneca prowling Europe for small deals
- Covance expands ops in Latin America
- Pharma cos offer pay hikes, bonus to lure employees
- ASEAN single pharma market comes a step closer
- Reliance Pharma unit ‘reconfigured’
- Contract jobs to keep pharma cos healthy
- Cashing in on demand for Lifestyle drugs
- Medicine firms need flexible pricing approach
- Sanofi Aventis to acquire Medley in Brazil
- Wockhardt to foray into biosimilar market
- Wanbury targets Rs 1,000-cr revenue by 2011-12
- How the over 100m-dollar deals change the face of domestic pharmaceutical industry
- Pharma firms struggle to handle debt overload
- 3 pharma majors eye Wockhardt's Irish unit
- Aurobindo Pharma receives first product approval for Finasteride Tab
- Uluru to Acquire York Pharma
- Re-evaluating pharma
- Sanofi Aventis-Piramal deal falls through over valuation
- Baddi bucks slowdown
- Medical diagnostic business on growth track
- Radhakrishna Foodland to pop pharma pill for growth
- Pharma dollars shifting to digital
- Understanding M&A motives
- Elder Pharma ties up with Chemische Fabrik Dr Weigert
- Foreign loans did not work for Wockhardt
- India second in medical tourism market reveals Deloitte study
- Cancer Research Foundation India floated for holistic management of cancer
- Manipal Hospital opens dedicated Cardio-Renal centre
- Pharma MNCs Raise India Stakes for Bigger Role
- More MNCs to Seek Stronger Control in Indian Market
- Nandini Piramal joins pharma business
- Google's US dollar 100M venture arm embracing biotech
- Bayer Schering Pharma restricts UK distribution
- India seeks pharmaceutical partnerships
- Piramal Healthcare to shut down unit in UK
- Pharma excellence awards to be presented at pharmaceutical leadership summit 2009.
- Time for some value picking
- Aurobindo gets Australia nod for anti-hypertension drugs
- Rs 761-cr package to revive IDPL ready'
- Kerala Drug Controller suggests a set of changes to D&C Act
- Union govt grants Rs 90 cr for starting 6 State Institute of Yoga & Naturopathy centres
- Abbott receives European Commission nod to acquire Advanced Medical Optics
- US FDA warns public of serious adverse event with psoriasis drug Raptiva
- New Pharma Park for SSIs to come up with the support of IDMA Gujarat
- Trivitron starts production of portable black and white ultrasound scanner
- Ethex recalls prescription prenatal & iron supplements products
- Cabinet clears proposals for 2 AIIMS-like institutes at cost of Rs 1640 crore
- NCRM ties up with Jeevan Blood Bank to open public stem cell bank in Chennai
- British health agency recommends Pfizer's Sutent for kidney cancer
- King Pharma to cut staff by 22 per cent
- Cluster project of Ayush Dept yet to take off after 2 years of announcement
- K'taka Drug control dept issues 323 show cause notices to pharmacy outlets
- Top Business News
- Lens produces hours of scientific work in seconds
- FDA seeks $4.5 billion to promote public health
- Medivation & Pfizer to terminate their collaboration to market development of Dimebon
- Antares Pharma Licenses A Drug Delivery Technology To Pfizer
- Research partnership between Humana and Pfizer
- Size of Indian Pharma Market
- New Vaccine for Malaria
- Teva might launch generic Lipitor: Analysts
- Indian pharmaceutical industry has tremendous potential to grow from the current levels
- Reddy formula
- GlaxoSmithKline Pharma: In sound health
- Brit scientists find way to store vaccines in room temp
- Pharmaceutical Advantage For India
- Pharma industry deserves priority status
- Russia invites Indian pharmas for joint ventures
- Biogen Idec lines up big India push
- GSK sees growth shot in vaccines
- Indian pharma in midst of corporate transformation
- From Oceans to Crops, and From Crops to IPO
- Pharma cos hope R and D sops will boost investment
- Expectation of Indian Pharmaceuticals and Health Science Industry
- Entry of Global Pharma in generics to put strain on Indian cos
- India still not lucrative for innovator drugs
- Elder Pharma opens drugmaking unit in Uttrakhand
- Excise removal can trigger Rs 5k crore pharma investment
- Opportunities galore in nanotechnology: IISER Director
- Soon, Cancer drugs at half-price from govt outlets
- Cipla retains top slot in domestic pharma market
- No place like home, finds Indian pharma
- Govt plans Rs 2,000 crore fund for pharma research
- Pfizer India, Arpana USAID Expand Public Private Partnership to Strengthen Healthcare Systems and
- Opportunities for NRIs to invest in pharma sector in India
- GSK inching closer to deal with Dr Reddys?
- Life science firms up hirings
- Bafna Pharma to focus mainly on life-style products
- Cadila Healthcare sets April date for the launch of H1N1 vaccine
- Pharmaceutical sector has capacity to double exports in five years
- Piramal Healthcare to raise Rs 10 bn in 6-8 months
- Pfizer, Like Much of Big Pharma, Pushes Further Into Generics
- Govt to examine Suns breast cancer drug
- Dishman sees Crams biz growing 20 percent
- Pharma cos see opportunity in India
- Pharma deals in India: 2009 precursor to what 2010 holds
- Dr Reddys to strengthen domestic business
- Glenmark to outlicense one molecule in FY10
- Dr Reddys all set to become 3-billion US dollars Company
- 2009 Cheers and Jeers for Pharma
- Vaccines enjoy renaissance in pharma industry
- Indian drugmakers leap ahead with Big Pharma
- Govt wants PSUs to make H1N1 drug
- 2009: The Year Pharma Learned to Love Itself
- As molecule deals fall, pharma firms see cure in late licensing
- Top pharma cos step up R and D spending to boost presence in regulated, emerging markets
- FMCG, pharma fledglings in for better days
- Outsourcing steroid for Indian pharma firms
- CRAMS factor
- Pharma groups plan anti-diarrhoea vaccine
- Gujarat pharmaceutical companies return home
- Modi asks pharma cos to focus on real research
- Vitamins or overpriced nutrients? Pharma firms face probe
- Cipla in talks to supply drugs to Germanys BI
- Blow the whistle on fake drugs, and get rewarded
- Aventis launches rural market division, eyes 2 per cent share in 5 yrs
- Pharma industry to need 2 lakh more grads by 2015
- Belgium-Gujarat diamond ties may extend to pharma
- Cracks in doctor freebies code
- Local firms must step up biologics play
- Piramal to strengthen diagnostic services
- India, Russia to raise bilateral trade to $20 bn
- Pharma firms to conduct H1N1 vaccine human trials in India
- Dragon emission cuts bite pharma industry
- DISCOUNT PILLS
- Indian pharma world discovers Bharat
- BUZZ IN PHARMA BIZ
- Govt to step up pharma research in country
- India has 'world-class health care', say Canadians
- Govt plans Rs 2,000-cr corpus for pharma sector
- Generating Synergies between India and Central Germany
- Aurobindo Pharma aims to treble revenue by 2014
- A.P. number one in pharma exports
- In healthcare, we can at best play catch-up with China
- Model N to spruce up India Operations
- Novo Nordisk eyes India as insulin hub for sub-continent
- Suven Life Sciences plans to raise funds for clinical trials
- Medicis deal, generic biz to boost financials
- Cipla's swine flu drug Antiflu hits market
- E7 the new El Dorado for pharma
- Watch out for US recovery, new products
- BIG PHARMA AND BIOTECH
- US health bill to benefit local generic firms
- Biocon hums with plans, pitches for global top 3 slot
- Zydus first Indian co to file H1N1 clinical trials
- NEW MERCK BEGINS OPERATIONS WORLDWIDE
- Not the right medicine
- Sikkim turns into a pharma hub
- Pharma club seeks protection from foreign predators
- Cadila Pharma eyes Rs 80 crore from Risorine
- Ranbaxy sells Vietnam biz, to exit another in growth bid
- India is growth tonic for mid-tier global pharma
- Pharma slows down, grows at 9.6 percent
- Big Pharma cures for ailing heritage
- Global Coalition to observe first ever World Pneumonia Day on November 2
- State continues to attract pharma industry
- Dabur India to merge Fem Care Pharma with itself
- Glaxo enters DMD drugs with Prosena
- NPPA wants generics branding out
- Vitamins boost pharma growth
- Dr Reddys net rises 106 percent on cost cuts, higher sales
- Pfizer scans India for shopping options
- Apollo Pharmacy licensed to retail Swine flu medicine
- Govt may cap retail price of swine flu drug
- India govt seeks Argentina to ease trade policy to increase pharma trade
- Pharma cos likely to emerge stronger in Q2
- Piramal Life lines up Rs 200 cr for new drug research
- Indian pharma market set to grow 12 to 15 percent
- American trio share Nobel Prize for hot area in pharma research
- Reflections On The Indo Africa Pharma Business Meet
- Growth in US, local market to pep up DRL
- Wipro GE Healthcare to integrate GE Healthcare units in India and South Asia to accelerate growth
- Indian formulation mkt to cross US dollars 13.7 billion by 2013
- Indias genetic divide may hit pharma cos R and D plans
- Pharma industry steps up recruitment 5 times
- Pharma M and As sounding death knell for low-cost drugs?
- Sanofi-Aventis scans India for acquisitions
- Pharma exports up 29 pc to US dollar 9.35 bn
- Wockhardt is top Indian pharma patentee bags government award
- Mega deals boost pharma in crisis
- Pfizer plans major push into generics
- Lotus aims to roll out 4 more centres next year
- 2009 India Excellence in Healthcare Awards
- Pharma cos will require DCGI nod for exports
- Annual India Excellence in Healthcare Awards to Celebrate Best in Industry
- Roles reverse in pharma M and As
- North Indian Pharma: Focusing on R and D and Tie-ups to Meet Challenging conditions
- Race for a H1N1 Swine Flu Vaccine
- India pharmaceutical market currently ranks 13th among the major global markets
- Big pharma companies join outsourcing queue
- Indian generics profit from Glaxo patent expiry
- Foreign pharma firms likely to beat Indian ones in developing vaccine
- Pharma sector in for an R and D boost from govt
- Pharma sector in good health in June quarter
- Low costs a draw for foreign drug makers
- Cadila Pharma plans swine flu vaccine by November
- Impact Of Current Global Conditions On Pharma and Biotech
- Pharmaceutical Outsourcing Congress India 2009
- Indias drug discovery efforts suffer failing health
- Opportunities for Indian drug makers in SA
- Generic drugs to carry quality mark
- Risk adjusted Vs absolute returns on pharma companies
- Indian Pharma mkt valued at Rs 55,000 cr in FY09
- Protectionism hurting Indias trade with EU: FICCI
- Sanofi Pasteurs Shantha buy a shot in the arm for Indian Pharma.
- India set to sign pharma export deal with Nigeria
- Pharma companies looking to Womens Health for growth
- Exploit more, explore less is Dr Reddys strategy in tough conditions
- A Patently Good Idea
- Frost & Sullivans Food & Beverage Focus 2009
- Pharma cos may show a mixed bag in Q1
- Indian pharma firms swallow bitter pill in US, Europe
- Animal Health offers growth for Big Pharma
- Israel ranks high in counterfeit pharmaceutical trade
- Pharma Accused of Keeping Good Generics Down
- Indian pharma firm sets up subsidiary in Romania
- Strong dollar beats down pharma revenues
- Gujarats 36 pharma brands among Indias top 300 cures
- Pandemic flu shows need for pharma incentives WHO
- Pharma body bans discounts, elderly cry foul
- Dark clouds loom on Big Pharma horizon
- HEADLINE: India - a force to be reckoned with?
- PerkinElmer expands presence in India with new Center of Excellence in Hyderabad
- EU Raps Big Pharma, Indian copycat kings boosted
- Pharmaceutical Industry at Crossroads
- Sun Pharmas US arm cuts 350 jobs
- Cadila Pharma-Novavax JV to produce swine flu vaccine
- Pharmas biggest boost comes from removal of fringe benefit tax news
- Big Pharma Looks To Branded Generics in Developing World
- ELDER PHARMACEUTICALS SETS UP ELVISTA A DIVISION DEDICATED TO TAP RURAL MARKETS
- Pharma giants feel afflicted with higher MAT
- FM has a heart, and a liver too
- Global pharma sales growth falls to 4.8% at US dollars 773 bn in 2008: IMS
- Pharma sector draws hope from Survey proposal on price controls
- Pharma industry hails survey recommendation on drug prices
- Pharma, not IT, is Indias next big thing
- Piramal to be first pvt company to process opium
- Sanofi-aventis presents new R & D model project to boost innovation
- Piramal Healthcare invests Rs 100 cr to expand business, sets up facilities in Ahmedabad, Chennai
- Japan's Astellas Pharma plans to enter Indian mkt
- Wockhardt to sell Animal Health Division to French firm
- From Thieves to Golden Geese
- Big Pharma comes calling to India
- Generic cos board biosimilars wagaon
- UK cos eye tie-ups to tap $1 bn clinical research market
- EU’s demands may impact generics
- China to Chennai is the new route for spurious medicines
- How Budget can help pharma sector
- Drug daddies keen to pop local deal pills
- Global Pharma majors impressed with Indian Bio-Pharma IP adherence
- Consolidation helps foreign pharma majors lead the India rank list
- Instant remedy: Pharma co ready with swine flu vaccine
- Report on pharma innovation to be released at USIBC meet
- Pfizer eyes deals to raise emerging markets presence
- Indian pharma faces the big-league challenge
- India lodges protest against Chinese drugs with fake 'Made in India' tag
- Big Pharma gets gold star on climate change scorecard
- Pfizer eyes partnerships, acquisitions in generics
- India to prepare case on drug confiscations at European ports
- India can become a global pharma innovation hub: experts
- Pharma firms continue to face patent violation charges in Europe
- To maintain quality of medicines, IGI to get pharma zone
- Drug makers eye Cambodia
- Pharma New World Order
- First indigenously developed Indian drug to come up in 2-4 yrs
- The pharmaceutical industry faces unprecedented barriers to evolution
- Life sciences industry awaits health supplement in Budget
- Evolvence to invest in Indian pharmaceutical companies
- Pharma industry seeks income tax exemption for R&D
- World Recession Slowing Down Global Pharmaceuticals
- Gujarat-based pharma firms in pink of health
- Heard on the Street
- Drug-resistant bacteria mute antibiotics R&D
- Indian Pharmaceutical Industry Capable of Dealing with Any Situation
- India now a player in M & A premier league
- Over 44 fixed-dose combination drugs clear DGCI tests
- Cardiome bags US 60 mn dollar from Merck as collaboration, license pact become effective
- Indian pharma players to benefit from generic drugs in US
- Pharma Trials Heading South
- Novartis nabs Ebewe for generics push
- Pfizer nabs generics, emerging-market rights
- Cancer drugs may come under NPPA lens
- Dr Reddys to tap rural, north Indian markets for growth Plans to increase products in therapeutic
- Japan’s Pharma Sees Growth in Generics
- Pharma firms look to profit from waste
- Pharma exports down on health cost cut in rich nations
- Ireland wants to increase bilateral trade with India
- Pharma cos want new govt to boost spending, push reforms
- The outsourcing boom grows for non-core pharma activities
- Pharma sector hails UPA win, expects continuity of eco reforms
- MNC units abroad to come under drug regulator scanner
- Lupin to raise stake in Australian firm to increase market presence
- Pharma cos seek retail opening for swine flu drug
- India looks to China for exports
- As pipeline dries, Big Pharma resorts to evergreening
- India`s pharma exports to US tumble 37%: report
- Pharma cos seek rise in prices of regulated drugs
- Global HIV/AIDS initiative to help Indian Pharma
- Glaxo goes deeper into Africa with US dollars 418M deal
- Govt moots setting up pharma zones at airports, seaports
- Pharma cos recast European operations to protect margins
- Pharma MNCs can't experiment with India yet
- Indian drug sales suffer
- Roche donates 5.65 mn packs of Tamiflu to WHO
- Logistics cos gear up to tap slump-proof pharma sector
- Pharma cos may have to start collaborating
- Indian pharma cos upbeat on biogenerics
- Kokilaben Hospital makes Trilogy radiation therapy available for first time in India
- India approaches WTO against EU on drug seizure issue
- Dip in US drug sales may hit Indian cos
- GSK calls for public health emergency of global concern
- US FDA authorizes emergency use of flu medicines, diagnostic test to tackle Swine flu outbreak in hu
- Not too enticing
- Govt gives diplomatic push to pharma exports to Africa
- India emerges as best option for contract manufacturing: Global Pharmatech Chief
- Indian Pharma Primed For Growth
- MNCs oppose affordable patented drugs
- IMS Health Cuts Pharma Growth Forecast
- Pharma cos adhere to EHS to attract global business
- Sanofi-aventis builds new manufacturing site in Binjiang New Development Zone
- Pharma welcomes UK taxation pledge
- China ripe for Big Pharma Growth
- Centre to talk MNC pharma cos into keeping a check on prices
- Pharma companies headed for slower earnings growth: analysts
- Drug firms may exceed growth targets
- ICCI for encouraging local pharma industry
- G20 economic stimulus packages offer little direct aid to branded pharmaceutical players
- India's Marck Biosciences Enters Malaysian Pharma Sector
- Abbott profits soar but pharma hit by generic competition
- Pharma giant Roche posts 7 pct sales growth
- Pharma cos have it tough this quarter
- Natco Pharma inks pact with Dr Reddy's Lab
- ASEAN single pharma market comes a step closer
- Pharma cos offer pay hikes, bonus to lure employees
- Reliance Pharma unit ‘reconfigured’
- Cashing in on demand for Lifestyle drugs
- Medicine firms need flexible pricing approach
- Contract jobs to keep pharma cos healthy
- Pharma firms struggle to handle debt overload
- How the over 100m-dollar deals change the face of domestic pharmaceutical industry
- Re-evaluating pharma
- Medical diagnostic business on growth track
- Pharma dollars shifting to digital
- Understanding M&A motives
- India second in medical tourism market reveals Deloitte study
- Cancer Research Foundation India floated for holistic management of cancer
- More MNCs to Seek Stronger Control in Indian Market
- Pharma MNCs Raise India Stakes for Bigger Role
- Nandini Piramal joins pharma business
- Google's US dollar 100M venture arm embracing biotech
- India seeks pharmaceutical partnerships
- Pharma excellence awards to be presented at pharmaceutical leadership summit 2009.
- Industry News
- International
- State
- Editorial
- Press Release
- White Papers
- Policy & Regulations
- Market Watch
- Sanofi aventis extends pact with Aureus Pharma for licence of DDI Predict 2009 Edition application
- Dishman joins hands with Californian firm
- MDS selling Pharma Services unit for 45 million US dollars
- Pharmaceutical Giants AstraZeneca (AZN), Rigel (RIGL) Collaborate On Arthritis Drug
- Alliance Pharma Gains 18 New Prescription Products in Acquisition
- Innovation is the key to pharma sector future
- Birla Kerala Vaidyashala to tie up with pharma cos for distrubtion
- Indoco, Watson Pharma in generics deal
- Strides Arcolabs looks to seal more drug supply deals with global pharma cos
- Novartis to leapfrog Alcon deal
- Domestic producers look for more of pharmaceutical rebound
- Despite slow growth, US stays drugmaker heaven
- Ranbaxy launches dermatological product 'Lulifin'
- Drug firms seeking panacea
- Lupin eyes acquisitions to gain market share
- French Pharma firm targets U.S., Europe markets
- Daiichi to use Ranbaxy network in Africa
- Seattle Genetics in licensing deal with Glaxo worth up to 402M US dollars
- OnocGenex, Teva in deal for cancer therapy
- Dr Reddys eyes brand buys in Russia, new launches here
- Top drug firms take in-licensing route to up sales
- Biostar Pharma to acquire Xian based medical equipment and nutrients manufacturer for 1.1 mn US doll
- Myriad Pharma to buy Javelin Pharma for 96 mln US dollars
- Era of big-ticket pharma buys fading
- US-based Hospira to buy Orchid Chemicals' injectables biz for $400 mn
- Cubist Pharma to acquire Calixa Therapeutics
- Japan pharma market a preferred destination for Indian cos
- Pharms year of merger mania
- Strides Arcolab Announces Conclusion of Court Process for Merger
- Piramal Healthcare eyeing overseas acquisitions: Swati Piramal
- Lupin plans to acquire firm in injectibles space in Japan
- GSK to continue M&As in emerging markets
- Ranbaxy to launch generic version of Flomax next year
- Dishman pharma forms JV to make API in Saudi Arabia
- Gloucester Pharma selling for $ 640M to Celgene
- Mylan sells stake in Concord Biotech
- Ranbaxy exits Nihon JV, sells out to partner
- Destination India, say surging numbers in Japan Inc
- German drug companies scout for India partners
- Avon to gain from nod to Ranbaxy's drug
- Mexico plans world-class medical research hub
- Jubilant extends collaboration with Eli Lilly
- Cipla in talks with global cos for research agreement
- Commerce Ministry & FICCI to organise Namaskar Africa
- BioInvent inks licensing pact with Daiichi Sankyo to discover & develop therapeutic antibodies
- Bafna Pharma to enter contract research, manufacturing
- India, the land of rising opportunities for Japan
- Novartis announces USD 1 billion investment to build largest pharmaceutical R and D institute in Chi
- Pfizer keen to buy Wockhardts biotech business
- Avesthagen forms global Joint Venture with Limagrain in Atash Seeds Private Limited.
- Sanofi-aventis sees new opportunities in Quebec
- Lupin targets buys in Gulf, Mexico, Brazil and Argentina
- Novartis & Vanda deal benefits Titan Pharma
- Merck acquires Sanmar biz in Bangalore
- Pfizer completes Wyeth merger
- Locus Pharma enters discovery research pact with Novartis
- Big Pharma targets emerging mkts
- Pharma enters emerging markets via generics
- Salix Pharma in US dollars 5M licensing deal with Lupin
- Glaxo eyes Dr Reddys as Big Pharma hunts in India
- Drug MNCs look at India as a market
- Sanofi aventis, Merrimack enter global collaboration
- Abbott to acquire Solvay Pharmaceuticals for US dollar 6.6 bn
- Glenmark plans cancer drug unit in Argentina
- Biocon, Amylin Pharma tie up to develop new diabetes drug
- Mid-cap pharma firms focus on LatAm market
- Yakult Danone India Pvt Ltd expands national footprint Launches Worlds No 1 Probiotic drink
- AVESTHAGEN to raise Rs. 700 crore from domestic and international markets
- Fortis inks Wockhardt deal
- P and G to sell Global Pharma biz for 3.1 bn dollars
- Pharma Giant Roche To Strengthen R and D Pipeline In Israel Through Pontifax Deal
- Pharma body questions proposal to boost exports
- Sandoz launches first generic version of Prograf capsules
- Sinclair Pharmss Sebclair launched in US by Dr Reddys unit as Promiseb
- MNCs eye Indian pharma
- Can Emerging Markets Save Pharma?
- Evotec enters fragment-based drug discovery pact with Cubist Pharma
- SciGen a big winner in human insulin deal with Bayer Schering Pharma AG
- The first largest pharma deal of the year: Advent buys Ozone
- BioSyent Pharma Signs License, Supply and Distribution Agreement
- Hisamitsu to buy Noven Pharma for 428 US dollars mln
- Zila inks merger agreement with Tolmar Holding
- Lupin buys global rights for US AllerNaze
- Genedata Signs Multi-Year Licensing Agreement with Chugai Pharmaceuticals
- Biocon inks tie-up with Mylan for generic biologic compounds
- Elder signs deal with US co for human trials of anti-cancer drug
- Wockhardt sells German arm to Mova Pharma
- Watson Pharma to Buy Arrow Group For 1.75B dollars In Cash, Stock
- Covidien leaps into new market with 130M dollars Nuvo deal
- Cegedim acquires the Nomi Group
- Dabur plans big expansion in skin care, to launch new brand
- Pharmexcil to setup expert cell to advise pharma SMEs in export, patent issues
- Pharmaceutical a Big Business
- Akela Pharma to buy Nventa Biopharma in stock deal of 1.4 mn Dollars
- Midmarket pharmaceutical deals could heat up
- Sciele Pharma to acquire privately held Victory Pharma
- Drug companies see acquisitions as prescription to health
- Growth in exports to regulated markets will boost pharma logistics business in India: Experts
- Ardea inks US dollars 407M cancer drug pact with Bayer
- Pfizer may buy RFCL's veterinary co for Rs 250 cr
- India to begin campaign to allay fears in African nations about quality of generics
- Indian cos eye Japan as next generic export market as margins decline in US, EU
- Sanofi spends US dollars126M to beef up in China
- Pharma deals booming in 2009
- Merck, Galapagos sign potential US dollars 251.7M deal
- GlaxoSmithKline near deal to acquire Stiefel Labs for about US dollars 3 bln
- Pharma exports in better health again-Surge in demand for low-cost generics
- Vyteris, Inc. (VYTR.OB) Signs Agreement with Zealand Pharma on Active Transdermal Patch for Peptide
- India, Brazil to object to MNCs dubbing generic drugs as counterfeits amongst African nations
- Marck Biosciences forays into Singapore, Malaysia
- World Vaccines Market 2008-2013 (Future Forecast, Critical Trends and Developments)
- Hungry Sanofi snaps up BiPar in $500M deal
- Pharma's Third Act
- Jubilant in pact with Finland-based firm for drug discovery
- Adcock Ingram to acquire Cipla Medpro
- Pharma exports cross US dollar 1 bn mark in December FY'09
- Fortis Healthcare acquires Lalitha Healthcare
- Sanofi, Biowa Ink Licensing Deal
- Sanofi in yet another emerging-market buyout
- Lupin signs agreement with Natco for Fosrenol
- Cardiome could get US dollar 600M in Merck heart drug pact
- Schering-Plough, Merck set US dollar 41.1B merger
- JAPAN'S OTSUKA PHARMA EXTENDS BRISTOL-MYERS SQUIBB DEAL TO '15
- The growth concoction-Pharma Mergers and acquisitions.
- Pharma exporters to dough trend, to grow 16% in 09-10
- Exporters may have to pay more for quality checks
- Pharmexcil designated to coordinate fast track approval of exports to Tajikistan
- Genzyme to acquire worldwide rights of Bayer's alemtuzumab
- iSOFT bags contracts in Spain worth US dollar 3.85 mn
- Novavax gets US dollar 11M, forges Indian joint venture
- Shire, GSK enter co-promotion pact for ADHD drug Vyvanse
- Genzyme gains MS drug rights in US dollar 2.8B deal
- Sigma-Aldrich, Gene Oracle ink supply pact to promote GeneIOS system & gene synthesis services
- Altea inks deal for transdermal Byetta patch
- Nitec Pharma signs license agreement with Mundipharma for Lodotra
- ReSearch Pharma acquires Paramax
- Aging Population & Healthcare Reforms Driving Russian Pharma
- Lupin completes acquisition of Multicare Pharmaceuticals
- Dishman Pharma inks pact with Polpharma of Poland
- Endo Pharma Completes Indevus Pharma Acquisition
- Drug cartel has throttlehold on Vietnam Market
- INDIAN PHARMA CO RANBAXY BUYS US DOLLAR 4 MLN WORTH OF RELIGARE SHARES
- Navigenics acquires Affymetrix Clinical Services Lab
- Lipoxen signs collaboration agreement with Glide Pharma
- Avesthagen Limited entered into a strategic alliance with Uxmal S.A
- March Madness Meets Pharma Merger Madness
- Big Pharma eyes rural India for growth
- Roche acquires German based Innovatis AG for 15 million Euros
- Japan Pharma to hold fire amid mega-M&A deals
- Enzo Biochem acquires Assay Designs for $12.2 million
- Covance Buys Swiss Pharma Contract
- Deals: Pharma Is the Cure for M&A's Blahs
- Jubilant inks pact with Guerbet to distribute nuclear medicine products in Europe
- Teikoku Pharma USA And Eisai Co., Ltd Announce Licensing Agreement
- Roche to buy Genentech for $46.8 bn
- Is Bristol-Myers the next pharma target?
- Big Pharma's new landscape :What do the M&A deals mean for the drug industry's future?
- Gilead $1.4 Bln CV Therapeutics Deal Tops Astellas
- Exports of pharma products surge 10%
- Pharma export to grow by 25%
- The perfect storm for pharma dealmaking
- M&A set to rise in pharma sector, analysts say
- Vertex Acquires ViroChem in $377M Cash-Stock Deal
- GAC extends pharmaceutical deal
- Pfizer ropes in Aurobindo to sell drugs in US
- Chinese move marks 'globalisation' of Bayer Schering R&D
- NanoViricides, Inc. Signs Agreement with a Major Pharma
- Proposal to establish warehouse in Russia gathering dust in commerce ministry
- Nuvo may get US FDA nod to market Pennsaid
- Eisai to sell Bial's anti-epileptic drug Zebinix in Europe
- Access, JCOM sign license pact to develop, commercialize ProLindac & MuGard
- acquires rights to UCB's Equasym IR & XL to treat ADHD
- EMEA recommends Wyeth's Conbriza for postmenopausal osteoporosis
- Global anti-aging products market to reach $291.9 billion by 2015
- Pharma companies eye new markets to drive sales
- Hamdard launches cholesterol drug Lipotab
- Wockhardt launches new insulin for diabetes in India
- Japan - Generics to Account for 29% Pharma Sales Volume by 2013
- Kamal Nath to meet European leaders on seizure of in-transit drug cargo at EU ports
- GSK, Genmab seek European marketing approval for leukaemia drug ofatumumab
- BioMarin's galsulfase receives Brazilian approval
- Guardian launches X-tra Vital food supplements
- Promed Exports to foray into US, Europe with focus on generic ophthalmic market
- APP Pharma launches Rocuronium Bromide injection
- Schering-Plough launches non-drowsy allergy medicine Claritin Liqui-Gels
- Abbott launches real-time PCR-based diagnostic test for HPV in Europe
- Victory Pharma launches additional Naprelan prescription products
- Bayer Diabetes Care launches new blood sugar control monitoring system
- RNCOS Releases a New Report- Ukraine Pharma - New Opportunities for Growth
- Transgene to manufacture four new drugs
- Indian authority asks pharma companies to reduce prices by 2.84%
- US FDA clears non-invasive test to help doctors manage heart transplant patients
- Truman Medical Centers Installs Adaptive 128-slice CT Scanner
- ICON Medical Imaging Launches New Service to Boost Reliability of Cardiology Studies
- Synapse Bio's respiratory device gets USFDA approval
- Market
- Deal Watch
- Sanofi aventis extends pact with Aureus Pharma for licence of DDI Predict 2009 Edition application
- Dishman joins hands with Californian firm
- MDS selling Pharma Services unit for 45 million US dollars
- Pharmaceutical Giants AstraZeneca (AZN), Rigel (RIGL) Collaborate On Arthritis Drug
- Birla Kerala Vaidyashala to tie up with pharma cos for distrubtion
- Alliance Pharma Gains 18 New Prescription Products in Acquisition
- Indoco, Watson Pharma in generics deal
- Strides Arcolabs looks to seal more drug supply deals with global pharma cos
- Domestic producers look for more of pharmaceutical rebound
- Novartis to leapfrog Alcon deal
- Lupin eyes acquisitions to gain market share
- OnocGenex, Teva in deal for cancer therapy
- Seattle Genetics in licensing deal with Glaxo worth up to 402M US dollars
- Biostar Pharma to acquire Xian based medical equipment and nutrients manufacturer for 1.1 mn US doll
- Myriad Pharma to buy Javelin Pharma for 96 mln US dollars
- Era of big-ticket pharma buys fading
- Cubist Pharma to acquire Calixa Therapeutics
- US-based Hospira to buy Orchid Chemicals' injectables biz for $400 mn
- Pharms year of merger mania
- Strides Arcolab Announces Conclusion of Court Process for Merger
- Piramal Healthcare eyeing overseas acquisitions: Swati Piramal
- Lupin plans to acquire firm in injectibles space in Japan
- Dishman pharma forms JV to make API in Saudi Arabia
- Ranbaxy exits Nihon JV, sells out to partner
- Mylan sells stake in Concord Biotech
- Gloucester Pharma selling for $ 640M to Celgene
- Avon to gain from nod to Ranbaxy's drug
- Jubilant extends collaboration with Eli Lilly
- Cipla in talks with global cos for research agreement
- BioInvent inks licensing pact with Daiichi Sankyo to discover & develop therapeutic antibodies
- Bafna Pharma to enter contract research, manufacturing
- Pfizer keen to buy Wockhardts biotech business
- Avesthagen forms global Joint Venture with Limagrain in Atash Seeds Private Limited.
- Lupin targets buys in Gulf, Mexico, Brazil and Argentina
- Locus Pharma enters discovery research pact with Novartis
- Pfizer completes Wyeth merger
- Merck acquires Sanmar biz in Bangalore
- Novartis & Vanda deal benefits Titan Pharma
- Glaxo eyes Dr Reddys as Big Pharma hunts in India
- Salix Pharma in US dollars 5M licensing deal with Lupin
- Sanofi aventis, Merrimack enter global collaboration
- Abbott to acquire Solvay Pharmaceuticals for US dollar 6.6 bn
- Biocon, Amylin Pharma tie up to develop new diabetes drug
- Fortis inks Wockhardt deal
- P and G to sell Global Pharma biz for 3.1 bn dollars
- Pharma Giant Roche To Strengthen R and D Pipeline In Israel Through Pontifax Deal
- MNCs eye Indian pharma
- The first largest pharma deal of the year: Advent buys Ozone
- SciGen a big winner in human insulin deal with Bayer Schering Pharma AG
- Evotec enters fragment-based drug discovery pact with Cubist Pharma
- BioSyent Pharma Signs License, Supply and Distribution Agreement
- Hisamitsu to buy Noven Pharma for 428 US dollars mln
- Lupin buys global rights for US AllerNaze
- Zila inks merger agreement with Tolmar Holding
- Genedata Signs Multi-Year Licensing Agreement with Chugai Pharmaceuticals
- Biocon inks tie-up with Mylan for generic biologic compounds
- Elder signs deal with US co for human trials of anti-cancer drug
- Wockhardt sells German arm to Mova Pharma
- Watson Pharma to Buy Arrow Group For 1.75B dollars In Cash, Stock
- Covidien leaps into new market with 130M dollars Nuvo deal
- Cegedim acquires the Nomi Group
- Akela Pharma to buy Nventa Biopharma in stock deal of 1.4 mn Dollars
- Midmarket pharmaceutical deals could heat up
- Sciele Pharma to acquire privately held Victory Pharma
- Drug companies see acquisitions as prescription to health
- Pfizer may buy RFCL's veterinary co for Rs 250 cr
- Ardea inks US dollars 407M cancer drug pact with Bayer
- Pharma deals booming in 2009
- Merck, Galapagos sign potential US dollars 251.7M deal
- GlaxoSmithKline near deal to acquire Stiefel Labs for about US dollars 3 bln
- Vyteris, Inc. (VYTR.OB) Signs Agreement with Zealand Pharma on Active Transdermal Patch for Peptide
- Hungry Sanofi snaps up BiPar in $500M deal
- Pharma's Third Act
- Jubilant in pact with Finland-based firm for drug discovery
- Adcock Ingram to acquire Cipla Medpro
- Cardiome could get US dollar 600M in Merck heart drug pact
- Lupin signs agreement with Natco for Fosrenol
- Sanofi in yet another emerging-market buyout
- Sanofi, Biowa Ink Licensing Deal
- Fortis Healthcare acquires Lalitha Healthcare
- Schering-Plough, Merck set US dollar 41.1B merger
- JAPAN'S OTSUKA PHARMA EXTENDS BRISTOL-MYERS SQUIBB DEAL TO '15
- The growth concoction-Pharma Mergers and acquisitions.
- Genzyme to acquire worldwide rights of Bayer's alemtuzumab
- iSOFT bags contracts in Spain worth US dollar 3.85 mn
- Novavax gets US dollar 11M, forges Indian joint venture
- Genzyme gains MS drug rights in US dollar 2.8B deal
- Sigma-Aldrich, Gene Oracle ink supply pact to promote GeneIOS system & gene synthesis services
- Altea inks deal for transdermal Byetta patch
- Nitec Pharma signs license agreement with Mundipharma for Lodotra
- ReSearch Pharma acquires Paramax
- Lupin completes acquisition of Multicare Pharmaceuticals
- Dishman Pharma inks pact with Polpharma of Poland
- Endo Pharma Completes Indevus Pharma Acquisition
- INDIAN PHARMA CO RANBAXY BUYS US DOLLAR 4 MLN WORTH OF RELIGARE SHARES
- Navigenics acquires Affymetrix Clinical Services Lab
- Lipoxen signs collaboration agreement with Glide Pharma
- Avesthagen Limited entered into a strategic alliance with Uxmal S.A
- March Madness Meets Pharma Merger Madness
- Roche acquires German based Innovatis AG for 15 million Euros
- Japan Pharma to hold fire amid mega-M&A deals
- Enzo Biochem acquires Assay Designs for $12.2 million
- Covance Buys Swiss Pharma Contract
- Deals: Pharma Is the Cure for M&A's Blahs
- Roche to buy Genentech for $46.8 bn
- Teikoku Pharma USA And Eisai Co., Ltd Announce Licensing Agreement
- Is Bristol-Myers the next pharma target?
- Big Pharma's new landscape :What do the M&A deals mean for the drug industry's future?
- Gilead $1.4 Bln CV Therapeutics Deal Tops Astellas
- Jubilant inks pact with Guerbet to distribute nuclear medicine products in Europe
- M&A set to rise in pharma sector, analysts say
- Vertex Acquires ViroChem in $377M Cash-Stock Deal
- The perfect storm for pharma dealmaking
- Pfizer ropes in Aurobindo to sell drugs in US
- GAC extends pharmaceutical deal
- NanoViricides, Inc. Signs Agreement with a Major Pharma
- Access, JCOM sign license pact to develop, commercialize ProLindac & MuGard
- Emerging Markets
- Products
- Machinery
- Export Import
- FDA
- Allied Sectors
- Events
- SME LEAD
- Pharma Vision
- Grape wine seed extracts slow down the growth rate of Cancer
- Stem Cell treatment can heal Heart attack damage
- Anti Measles Vaccination Drive
- Bat Plant can Fight Against Cancer
- FDA Warns Against Usage of Needle Free Flu Vaccine
- KG5 a wonder drug to kill cancer
- America's hottest diet craze
- Air freshener dangerous to health
- Light fights against Cancer
- Coffee lowers risk of Skin Cancer
- 3SBio ties up with Ascentage Pharma to develop and commercialize cancer therapeutics
- Blow to Cadila’s H1N1 vaccine plan
- TCG Lifesciences, Pfizer ink drug research pact
- Dr Reddys completes phase III trials
- Eisai to make AP facility as global R&D hub
- Dr Reddys anti-cholesterol drug reaches Phase II trials
- GE Healthcare launches FTA DMPK cards for storage of study samples
- Ecron Acunova opens new office in Russia to tap clinical trials opportunities
- Pharma Dept moots a string of measures to boost research in pharma industry
- Growing pharma market makes India a clinical trial destination: Report
- Lilly Reports on Outcome of Phase III Study of Arzoxifene
- India a preferred destination for clinical trials
- Xeloda-Oxaliplatin Combination (Xelox) Shown to Be More Effective Than Standard Chemotherapy Regime
- Major pharma cos commences human trials of seven candidate TB drugs
- India turns hub of clinical research outsourcing
- Seattle Genetics, Millennium ink collaboration pact to develop ADCs
- NovaBay, Galderma ink pact to develop & commercialize Aganocide drugs for skin disease
- Lilly inks US dollar 300M R&D pact with Cadila
- CROs call for better regulatory environment to attract more business
- ICRI, Cranfield Univ, UK open admissions for PG course in clinical research
- MDRNA & Novartis in licensing pact for liposomal technology platform for siRNA delivery
- New Millennium initiative projects successful in developing many new molecules
- Medivation receives US FDA nod to begin phase 3 trial of prostate cancer drug
- Bayer inks pact with Tsinghua University to establish joint research centre in China.
- Avanir Pharma completes patient enrolment in phase-III trial of Zenvia
- Pharma’s Ongoing Quest for R&D Innovation
- Cyclogenix enters research pact with Wyeth & Queensland's IMBcom
- Waters XenoTech LLC offers drug industry new metabolite profiling
- Defence Research Lab identified potential herbs to develop malaria drug from North East
- Sciele, Plethora complete patient recruitment in phase III trial of premature ejaculation drug
- Seattle Genetics initiates Hodgkin lymphoma drug trial
- Big Pharma relies on India, China for R&D
- Globalization of Clinical Trials: Another Hole in Pharma Regulation?
- Genentech, NCI to enter co-operative R&D pact for cancer drug
- Bayer Schering Pharma to open Beijing R&D center
- Study shows MS patients treated with Tysabri remain free of disease activity for two years
- ICMR, Intl AIDS Vaccine Initiative to carry out phase-I of combination AIDS vaccine trial
- Ligand, Trevena enter joint research & license pact
- Bioneeds invests $2 mn for canine unit, GLP certification, scouts for partners
- Dyax expands antibody discovery collaboration with Biogen Idec
- Osiris Therapeutics Enters a New Age of Pharma Risk and Profit Share
- ICMR to research on 'long term effects of MIC gas' on Bhopal population
- Merck's phase 3 trial of safinamide as adjunctive therapy to levodopa meets endpoint
- Researchers found new cause of ozone wheezing
- Aastrom puts phase II IMPACT-DCM trial on hold due to serious adverse event in one patient
- Anna varsity, Apollo Foundation to launch PG course in clinical trial management
- Cenix signs research pact with Boehringer Ingelheim for RNAi-based target discovery
- New study shows Lipitor reduces hsCRP levels in patients with stable coronary artery disease
- Pfizer's Geodon effective adjunctive treatment for bipolar disorder
- Endo Pharma & Alexza Pharma conclude research pact
- CCRAS to launch database on traditional medicines research
- King Pharma's Embeda safe for long-term chronic pain therapy
- Pfizer discontinues phase III trial in pancreatic cancer drug axitinib
- R & D
- Clinical Trials
- Trends & Analysis
- Special Reports
- Movements
Powered by Xmap! |
|
|
| |
